Literature DB >> 8393640

Amounts of angiotensin-converting enzyme mRNA reflect the burden of granulomas in granulomatous lung disease.

S Gilbert1, D S Steinbrech, S K Landas, G W Hunninghake.   

Abstract

A number of granulomatous lung diseases, including sarcoidosis, are associated with an increase in angiotensin-converting enzyme (ACE) activity. To evaluate whether the amount of ACE activity reflects the burden of granulomas, we used an animal model of granulomatous lung disease caused by injecting killed Mycobacterium butyricum intravenously into mice after a primary intracutaneous injection with Freund's complete adjuvant. In this model, essentially all of the granulomas are present in the lung. RNA was isolated from one lung and assayed for ACE mRNA. The other lung was evaluated histologically; the area of lung occupied by granulomas was determined by morphometry. We found that total lung RNA and RNA specific for ACE increased in close correlation with the area of granulomas. These findings provide direct evidence that the amount of ACE activity in granulomatous disease reflects the total burden of granulomas. This may be a useful model to further evaluate ACE regulation in granulomatous lung disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8393640     DOI: 10.1164/ajrccm/148.2.483

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  9 in total

1.  [Manifestations of autoimmune disorders in otorhinolaryngology : Classical symptoms and diagnostic approach].

Authors:  B Hofauer; A Chaker; K Thürmel; A Knopf
Journal:  HNO       Date:  2017-08       Impact factor: 1.284

2.  The Immunogenetics of Granulomatous Diseases.

Authors:  Gizem Filazi Kök; Ümit Türsen
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

3.  Usefulness of Combined Measurement of Serum Soluble IL-2R and Angiotensin-Converting Enzyme in the Detection of Uveitis Associated with Japanese Sarcoidosis.

Authors:  Mami Ishihara; Akira Meguro; Mizuho Ishido; Masaki Takeuchi; Etsuko Shibuya; Nobuhisa Mizuki
Journal:  Clin Ophthalmol       Date:  2020-08-12

4.  18F-FDG PET, genotype-corrected ACE and sIL-2R in newly diagnosed sarcoidosis.

Authors:  Ruth G Keijsers; Fred J Verzijlbergen; Wim J Oyen; Jules M van den Bosch; Henk J Ruven; Heleen van Velzen-Blad; Jan C Grutters
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-04       Impact factor: 9.236

5.  Imbalance of pro- and anti-inflammatory cytokines in pulmonary sarcoidosis.

Authors:  J Müller-Quernheim
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

6.  Elevated aminotransaminases as the first manifestation of sarcoidosis.

Authors:  Georges Nawfal; Christelle Budin; Raymonde Bouvier; Alain Lachaux
Journal:  Case Rep Med       Date:  2009-05-26

7.  Interleukin-2 Receptor and Angiotensin-Converting Enzyme as Markers for Ocular Sarcoidosis.

Authors:  Enken Gundlach; Michael Marcus Hoffmann; Antje Prasse; Sonja Heinzelmann; Thomas Ness
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240

8.  Reduced expression of monocyte CD200R is associated with enhanced proinflammatory cytokine production in sarcoidosis.

Authors:  Simon D Fraser; Laura R Sadofsky; Paul M Kaye; Simon P Hart
Journal:  Sci Rep       Date:  2016-12-08       Impact factor: 4.379

9.  Pulmonary sarcoidosis with and without extrapulmonary involvement: a cross-sectional and observational study in China.

Authors:  Cheng-Wei Li; Ru-Jia Tao; Dan-Feng Zou; Man-Hui Li; Xin Xu; Wei-Jun Cao
Journal:  BMJ Open       Date:  2018-02-16       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.